在药理学中设计公平和包容的评估:从医学科学教育实践的见解
相关实验视频
Updated: Jan 11, 2026

10:07
Using Learning Outcome Measures to assess Doctoral Nursing Education
Published on: June 21, 2010
19.3K
Brendan Wilkins1, Elvan Djouma2
1Department of Pharmacology, School of Biomedical Sciences, University of New South Wales, Sydney, New South Wales, Australia.
British journal of clinical pharmacology
|November 19, 2025
概括
药理学中的包容性评估确保了所有学生的公平学习机会. 这种方法对于公平的评估和发展多元化的医疗保健工作人员至关重要.
科学领域:
- 医学教育 医学教育
- 卫生科学 卫生科学 卫生科学
- 药理学教育教育 药理学教育
背景情况:
- 包容性评估在高等教育中至关重要,特别是在药理学等高风险领域.
- 公平,多样性和包容 (EDI) 原则正在越来越多地塑造教育战略.
- 多样化的学生群体需要公平和可访问的评估方法.
研究的目的:
- 审查药理学和健康科学中包容性评估的理论和实践方面.
- 突出创新的战略,为公平的学生评价.
- 识别和解决实施包容性评估的挑战.
主要方法:
- 文献综述检查了包容性评估的理论基础.
- 分析药理学中的实际应用和创新策略.
- 识别实施的系统和机构障碍.
主要成果:
- 包容性评估实践促进公平性和不同学习者的学术成功.
- 创新策略可以加强药理学中的公平评估.
- 系统性挑战可能会阻碍采用包容性评估.
结论:
- 将EDI整合到药理学评估中对于一个公平和响应式的学习环境至关重要.
- 提出了基于证据的建议,以克服实施障碍.
- 包容性评估支持发展多元化和有能力的医疗保健工作人员.
相关概念视频
Measurement of Bioavailability: Pharmacodynamic Methods
221
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
221
Pharmacokinetic Models: Comparison and Selection Criterion
314
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
314
Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
Biopharmaceutical Factors Influencing Drug Product Design: Overview
222
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
222
Dosage Regimens: Designs and Approaches
246
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
246
Dosage Regimens: Partial Pharmacokinetic Parameters
138
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
138

